HuGE Literature Finder
Records
1
-
30
| Genomic Profiling Reveals Novel Predictive Biomarkers for Chemo-Radiotherapy Toxicity and Efficacy in Non-Small-Cell Lung Cancer. International journal of radiation oncology, biology, physics 2021 Nov 111 (3S): e437. He K, Zhang S, Pang J, Yin J, Zhang J, Mu D, Tang S, Li L, Bao H, Wu X, Wang X, Shao Y, Yu J, Yuan |
| NQO1 C609T polymorphism and lung cancer susceptibility: Evidence from a comprehensive meta-analysis. Oncotarget 2017 Nov 8 (60): 102301-102309. Huang Jiawen, Lin Huiran, Wu Xiaosong, Jin Weijun, Zhang Zhido |
| Biological interaction of cigarette smoking on the association between genetic polymorphisms involved in inflammation and the risk of lung cancer: A case-control study in Japan. Oncology letters 2017 May 13 (5): 3873-3881. Yamamoto Yuzo, Kiyohara Chikako, Suetsugu-Ogata Saiko, Hamada Naoki, Nakanishi Yoic |
| Interactive effect of smoking and NQO1 haplotypes on lung cancer risk. Journal of Korean medical science 2015 Mar 30 (3): 221-6. Kim Jin Hee, Hong Yun-Ch |
| Increased NQO1 but not c-MET and survivin expression in non-small cell lung carcinoma with KRAS mutations. International journal of environmental research and public health 2014 Sep 11 (9): 9491-502. Yilmaz Ahmet, Mohamed Nehad, Patterson Kara A, Tang Yan, Shilo Konstantin, Villalona-Calero Miguel A, Davis Michael E, Zhou Xiaoping, Frankel Wendy, Otterson Gregory A, Beall Howard D, Zhao Weiqia |
| The role of NQO1 polymorphisms in the susceptibility and chemotherapy response of Chinese NSCLC patients. Cell biochemistry and biophysics 2014 Jul 69 (3): 475-9. Tian Gang, Wang Miaomiao, Xu Xiaoga |
| Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer. International journal of clinical and experimental pathology 2014 7 (10): 6743-51. Kim Ho-Cheol, Song Joon Seon, Lee Jae Cheol, Lee Dae Ho, Kim Sang-We, Lee Jung-Shin, Kim Woo Sung, Rho Jin Kyung, Kim Sun Ye, Choi Chang-M |
| Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics 2014 15 (12): 1565-74. Lamba Jatinder Kaur, Fridley Brooke L, Ghosh Taraswi M, Yu Qing, Mehta Gaurav, Gupta Pank |
| NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and lung cancer risk: a meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Dec 34 (6): 3967-79. Lou Yuqing, Li Rong, Xiong Liwen, Gu Aiqin, Shi Chunlei, Chu Tianqing, Zhang Xueyan, Gu Ping, Zhong Hua, Wen Shaojun, Han Baoh |
| Aromatic DNA adducts and number of lung cancer risk alleles in Map-Ta-Phut Industrial Estate workers and nearby residents. Mutagenesis 2013 Jan 28 (1): 57-63. Peluso Marco, Srivatanakul Petcharin, Jedpiyawongse Adisorn, Sangrajrang Suleeporn, Munnia Armelle, Piro Sara, Ceppi Marcello, Boffetta Paolo, Godschalk Roger W L, van Schooten Frederik |
| C609T Polymorphism of NADPH Quinone Oxidoreductase 1 Correlates Clinical Hematological Toxicities in Lung Cancer Patients Treated with Amrubicin. Clinical Medicine Insights. Oncology 2013 7 31-9. Nagata Misato, Kimura Tatsuo, Suzumura Tomohiro, Kira Yukimi, Nakai Toshiyuki, Umekawa Kanako, Tanaka Hidenori, Matsuura Kuniomi, Mitsuoka Shigeki, Yoshimura Naruo, Oka Takako, Kudoh Shinzoh, Hirata Kazu |
| Lack of association between NADPH quinone oxidoreductase 1 (NQO1) gene C609T polymorphism and lung cancer: a case-control study and a meta-analysis. PloS one 2012 7 (10): e47939. Guo Shujie, Gao Min, Li Xiaobo, Li Yuqiong, Chu Shaoli, Zhu Dingliang, Niu Wenqu |
| The NQO1*2/*2 polymorphism is associated with poor overall survival in patients following resection of stages II and IIIa non-small cell lung cancer. Oncology reports 2011 Jun 25 (6): 1765-72. Kolesar Jill M, Dahlberg Suzanne E, Marsh Sharon, McLeod Howard L, Johnson David H, Keller Steven M, Schiller Joan |
| Genetic modifiers of carcinogen DNA adducts in target lung and peripheral blood mononuclear cells. Carcinogenesis 2010 Dec 31 (12): 2091-6. Lee Mi-Sun, Su Li, Mark Eugene J, Wain John C, Christiani David |
| Genetic polymorphisms of MPO, GSTT1, GSTM1, GSTP1, EPHX1 and NQO1 as risk factors of early-onset lung cancer. International journal of cancer. Journal international du cancer 2010 Oct 127 (7): 1547-61. Timofeeva Maria, Kropp Silke, Sauter Wiebke, Beckmann Lars, Rosenberger Albert, Illig Thomas, Jäger Birgit, Mittelstrass Kirstin, Dienemann Hendrik, , Bartsch Helmut, Bickeböller Heike, Chang-Claude Jenny, Risch Angela, Wichmann Heinz-Eri |
| Additional candidates to conventional genes susceptible for lung cancer and changing trend in Japan. Oncology reports 2010 Jun 23 (6): 1493-500. Okazaki Isao, Sugita Minoru, Matsuki Hideaki, Billah Syed Muhammad Baqui, Watanabe Tet |
| Clinical significance of NQO1 C609T polymorphisms after postoperative radiation therapy in completely resected non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 2009 Jul . Song SY, Jeong SY, Park HJ, Park SI, Kim DK, Kim YH, Shin SS, Lee SW, Ahn SD, Kim JH, Lee JS, Choi EK |
| Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women. Carcinogenesis 2009 Apr 30 (4): 626-35. Cote Michele L, Yoo Wonsuk, Wenzlaff Angela S, Prysak Geoffrey M, Santer Susan K, Claeys Gina B, Van Dyke Alison L, Land Susan J, Schwartz Ann |
| Influence of NQO1, ALDH2, and CYP2E1 genetic polymorphisms, smoking, and alcohol drinking on the risk of lung cancer in Koreans. Cancer causes & control : CCC 2009 Mar 20 (2): 137-45. Eom Sang-Yong, Zhang Yan Wei, Kim Sung-Hoon, Choe Kang-Hyeon, Lee Kye Young, Park Jung-Duck, Hong Yun-Chul, Kim Yong-Dae, Kang Jong-Won, Kim He |
| Combined effects of genetic polymorphisms in six selected genes on lung cancer susceptibility. Lung cancer (Amsterdam, Netherlands) 2007 Aug 57 (2): 135-42. Yang Mihi, Choi Yunhee, Hwangbo Bin, Lee Jin S |
| Genetic susceptibility according to three metabolic pathways in cancers of the lung and bladder and in myeloid leukemias in nonsmokers. Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007 Jul 18 (7): 1230-42. Vineis P, Veglia F, Garte S, Malaveille C, Matullo G, Dunning A, Peluso M, Airoldi L, Overvad K, Raaschou-Nielsen O, Clavel-Chapelon F, Linseisen J P, Kaaks R, Boeing H, Trichopoulou A, Palli D, Crosignani P, Tumino R, Panico S, Bueno-De-Mesquita H B, Peeters P H, Lund E, Gonzalez C A, Martinez C, Dorronsoro M, Barricarte A, Navarro C, Quiros J R, Berglund G, Jarvholm B, Day N E, Key T J, Saracci R, Riboli E, Autrup |
| NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006 May 15 (5): 979-87. Chao Chun, Zhang Zuo-Feng, Berthiller Julien, Boffetta Paolo, Hashibe M |
| CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study. Carcinogenesis 2005 Dec 26 (12): 2207-12. Wenzlaff A S, Cote M L, Bock C H, Land S J, Santer S K, Schwartz D R, Schwartz A |
| Polymorphisms of the GSTM1, GSTP1, MPO, XRCC1, and NQO1 genes in Chinese patients with non-small cell lung cancers: relationship with aberrant promoter methylation of the CDKN2A and RARB genes. Cancer genetics and cytogenetics 2005 Oct 162 (1): 10-20. Chan Eunice C, Lam Shui Y, Fu Kin H, Kwong Yok |
| NQO1, MPO, and the risk of lung cancer: a HuGE review. Genetics in medicine : official journal of the American College of Medical Genetics 2005 Sep 7 (7): 463-78. Kiyohara Chikako, Yoshimasu Kouichi, Takayama Koichi, Nakanishi Yoic |
| Polymorphisms in genes involved in xenobiotic metabolism and lung cancer risk under the age of 60 years. A pooled study of lung cancer patients in Denmark and Norway. Lung cancer (Amsterdam, Netherlands) 2005 May 48 (2): 187-99. Skuladottir Halla, Autrup Herman, Autrup Judith, Tjoenneland Anne, Overvad Kim, Ryberg David, Haugen Aage, Olsen Jørgen |
| An association between a NQO1 genetic polymorphism and risk of lung cancer. Mutation research 2005 Apr 582 (1-2): 71-8. Saldivar Salvador J, Wang Yunfei, Zhao Hua, Shao Lina, Lin Jie, Spitz Margaret R, Wu Xife |
| Genetic polymorphisms in CYP1B1, GSTA1, NQO1 and NAT2 and the risk of lung cancer. Cancer letters 2005 Apr 221 (2): 185-90. Sørensen Mette, Autrup Herman, Tjønneland Anne, Overvad Kim, Raaschou-Nielsen O |
| NQO1 T allele associated with decreased risk of later age at diagnosis lung cancer among never smokers: results from a population-based study. Carcinogenesis 2005 Feb 26 (2): 381-6. Bock C H, Wenzlaff A S, Cote M L, Land S J, Schwartz A |
| [Studies of the genes related to lung cancer susceptibility in Nanjing Han population, China]. Yi chuan = Hereditas / Zhongguo yi chuan xue hui bian ji 2004 Sep 26 (5): 584-8. Liang Ge-Yu, Pu Yue-Pu, Yin Li-Ho |
- Page last reviewed:Jul 25, 2022
- Page last updated:Nov 28, 2022
- Content source: